Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Strategic Asset Allocation Index
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Strategic Asset Allocation Index of 19.1% as of June 2023. Strategic assets (PP&E of €6.77 Billion plus long-term investments of €-) total €6.77 Billion, measured against net assets of €35.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Strategic Asset Allocation Index (2013–2022)
This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Strategic Asset Allocation Index has evolved across 10 annual periods from 2013 to 2022. As of June 2023, the index stands at 19.1%, representing strategic assets of €6.77 Billion against net assets of €35.38 Billion EUR. Explore GU5 cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2022, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Guangzhou Baiyunshan Pharmaceutical Hold worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.5% | €6.57 Billion | €6.57 Billion | €- | €33.64 Billion | ▲ +1.4 pp |
| 2021 | 18.1% | €5.68 Billion | €5.68 Billion | €- | €31.33 Billion | ▲ +0.1 pp |
| 2020 | 18.1% | €5.10 Billion | €5.10 Billion | €- | €28.21 Billion | ▲ +1.0 pp |
| 2019 | 17.1% | €4.44 Billion | €4.44 Billion | €- | €25.99 Billion | ▼ -7.6 pp |
| 2018 | 24.7% | €5.72 Billion | €3.65 Billion | €2.07 Billion | €23.14 Billion | ▼ -3.4 pp |
| 2017 | 28.1% | €5.41 Billion | €2.37 Billion | €3.05 Billion | €19.26 Billion | ▼ -0.1 pp |
| 2016 | 28.2% | €4.98 Billion | €2.36 Billion | €2.62 Billion | €17.65 Billion | ▼ -28.6 pp |
| 2015 | 56.8% | €4.93 Billion | €2.49 Billion | €2.44 Billion | €8.68 Billion | ▲ +1.6 pp |
| 2014 | 55.2% | €4.37 Billion | €2.29 Billion | €2.08 Billion | €7.92 Billion | ▼ -2.6 pp |
| 2013 | 57.8% | €4.06 Billion | €2.07 Billion | €1.99 Billion | €7.02 Billion | — |